SMARCA5 and kidney cancer: The results showed that the expression levels of AC004837.2, FOXD2-AS1, LINC02154, and MINCR were significantly increased in kidney cancer cells compared with normal cells, whereas AL078581.2, LINC01671, and SMARCA5-AS1 were downregulated in kidney cancer cells (Figures 9(h)–9(n)).